- US-listed companies
- Bionik Laboratories Corp.
- Balance sheet
Bionik Laboratories Corp. (BNKL) Balance sheet
Market cap
$12.48
P/E ratio
| 2011/12 | 2014/12 | 2015/12 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | |
| Cash and cash equivalents | 12,455 | - | 7 | 543,650 | 507,311 | 446,779 | 2 | 1 | 2 | 427,383 |
| Total cash & short-term investments | 12,455 | - | 7 | 543,650 | 507,311 | 446,779 | 2 | 1 | 2 | 427,383 |
| Accounts receivable, net | - | - | - | 383,903 | 212,730 | 2 | 846,964 | 451,905 | 274,844 | 453,084 |
| Inventories | - | - | - | 228,249 | 237,443 | 405,682 | 1 | 692,163 | 1 | 1 |
| Total current assets | 12,455 | 3,242 | 7 | 1 | 1 | 4 | 6 | 3 | 5 | 3 |
| Property, plant and equipment, net | - | - | 87,103 | 227,421 | 159,961 | 192,528 | 154,144 | 93,577 | 91,234 | 187,673 |
| Total non-current assets | - | - | 87,103 | 28 | 27 | 27 | 13 | 5 | 91,234 | 584,569 |
| Total assets | 12,455 | 3,242 | 7 | 29 | 29 | 31 | 19 | 9 | 5 | 3 |
| Accounts payable | - | - | 134,718 | 784,726 | 724,673 | 1 | 857,093 | 454,809 | 305,095 | 557,610 |
| Total current liabilities | 6,332 | 42,580 | - | 6 | 8 | 3 | 5 | 4 | 1 | 2 |
| Long-term debt, non-current | - | - | - | - | - | - | - | 1 | - | - |
| Total non-current liabilities | - | - | - | - | - | - | - | 1 | 256,646 | 3 |
| Total liabilities | 6,332 | 42,580 | 6 | - | - | - | - | 6 | 2 | 5 |
| Common stock and paid-in capital | 18,650 | 4,986,193 | 11 | 45 | 56 | 74 | 85 | 88 | 98 | 99 |
| Retained earnings | - | - | -10,647,888 | -15,588,554 | -35,776,340 | -46,357,373 | -71,373,870 | -84,994,327 | -95 | -100 |
| Stockholders' equity | 6,123 | -39,338 | 977,988 | 23 | 20 | 27 | 13 | 3 | 3 | -1,640,588 |
| Total debt | - | - | - | - | - | - | - | 1 | - | - |
| Net debt | - | - | - | - | - | - | - | 505,974 | - | - |
| D/E ratio (%) | - | - | - | - | - | - | - | 33.7 | - | - |
| Working capital | - | - | - |